LY 2606368
|
5-[[5-[2-(3-氨基丙氧基)-6-甲氧基苯基]-1H-吡唑-3-基]氨基]-2-吡嗪甲腈
|
1234015-52-1
|
SC75741
|
SC75741
|
913822-46-5
|
1,4,8-Triazaspiro[4.5]decan-2-one, 8-methyl-1-(phenylmethyl)-
|
1-芐基-8-甲基-1,4,8-三氮雜螺[4.5]癸烷-2-酮
|
1224591-33-6
|
CAY10594
|
CAY10594
|
1130067-34-3
|
AX20017
|
AX 20017
|
329221-38-7
|
GSK2141795
|
UPROSERTIB
|
1047634-65-0
|
TBK1/IKKε-IN-2
|
CS-1801
|
1292310-49-6
|
Idalopirdine
|
LU AE58054
|
467459-31-0
|
Guanoclor
|
胍氯酚
|
5001-32-1
|
GSK2643943A
|
GSK2643943A
|
2449301-27-1
|
Etalocib
|
Etalocib
|
161172-51-6
|
SGC2085
|
SGC2085
|
1821908-48-8
|
SAR131675
|
SAR131675
|
1433953-83-3
|
UNC2541
|
UNC2541
|
1612782-86-1
|
HA130
|
HA 130,自分泌運動抑制劑
|
1229652-21-4
|
HG-14-10-04
|
CS-1175
|
1356962-34-9
|
HG-9-91-01
|
N-(2,4-二甲氧基苯基)-N'-(2,6-二甲基苯基)-N-[6-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-4-嘧啶基]脲
|
1456858-58-4
|
BTK IN-1
|
SNS062
|
1270014-40-8
|
Ibiglustat
|
GENZ-682452
|
1401090-53-6
|
FAUC 365
|
FAUC-365
|
474432-66-1
|
MELK-8a hydrochloride
|
MELK-8a
|
1922153-17-0
|
BMS-1166
|
BMS-1166
|
1818314-88-3
|
2-DIETHYLAMINOETHYL 1-(4-NITROPHENYL)CYCLOPENTANECARBOXYLATE HYDROCHLORIDE
|
化合物NITROCARAMIPHEN HYDROCHLORIDE
|
98636-73-8
|
KHS 101
|
KHS101
|
1262770-73-9
|
Quisinostat
|
JNJ 26854165
|
875320-29-9
|
Elesclomol
|
伊利司莫 Elesclomol
|
488832-69-5
|
5-(4,6-dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine
|
PI3K/MTOR抑制劑
|
1225037-39-7
|
Ezutromid
|
依珠曲米
|
945531-77-1
|
Acetamide, 2-chloro-N-(2,2-dimethylpropyl)-N-(tetrahydro-1,1-dioxido-3-thienyl)-
|
Acetamide, 2-chloro-N-(2,2-dimethylpropyl)-N-(tetrahydro-1,1-dioxido-3-thienyl)-
|
2451481-08-4
|
Uprosertib
|
TP0463518
|
1558021-37-0
|
bis-2-(5-PhenylacetMido-1,2,4-Thiadiazol-2-yl)Ethyl Sulfide
|
BPTES
|
314045-39-1
|
E7820
|
CS-2701
|
289483-69-8
|
HG-10-102-01
|
[4-[[5-氯-4-(甲基氨基)-2-嘧啶基]氨基]-3-甲氧基苯基]-4-嗎啉基甲酮
|
1351758-81-0
|
MRTX1133
|
MRTX1133
|
2621928-55-8
|
ZZW-115 hydrochloride
|
ZZW-115 hydrochloride
|
10122-45-9
|
Pirmenol
|
Pirmenol
|
68252-19-7
|
GSK8612
|
GSK8612
|
2361659-62-1
|
Sobetirome
|
SOBETIROME
|
211110-63-3
|
JAK3-IN-6
|
JAK3-IN-6
|
1443235-95-7
|
BP 897
|
N-[4-[4-(2-甲氧基苯基)-1-哌嗪基]丁基]-2-萘甲酰胺單鹽酸鹽
|
314776-92-6
|
BMS-1001 hydrochloride
|
BMS-1001
|
2113650-04-5
|
BCI
|
BCI
|
1245792-51-1
|
GDC0575 monohydrochloride
|
GDC0575 HYDROCHLORIDE
|
1196504-54-7
|
ZT-12-037-01
|
ZT-12-037-01
|
2328073-61-4
|
PF-06260933
|
化合物PF6260933
|
1811510-56-1
|
OT-R antagonist 1
|
化合物 T12331L
|
364071-17-0
|
NCT-503
|
NCT503
|
1916571-90-8
|
Desciclovir
|
地昔洛韋
|
84408-37-7
|
SEA0400
|
2-[4-[(2,5-二氟苯基)甲氧基]苯氧基]-5-乙氧基苯胺
|
223104-29-8
|
BCH001
|
化合物 BCH001
|
384859-58-9
|
PubChem ID: 397887
|
LMP744; LMP-744; LMP 744; MJ-III-65; NSC-706744
|
308246-57-3
|
SC 144
|
吡嗪羧酸 2-(7-氟吡咯并[1,2-A]喹喔啉-4-基)酰肼
|
895158-95-9
|
KO-947
|
KO-947
|
1695533-89-1
|
INARIGIVIR SOPROXIL
|
INARIGIVIR SOPROXIL
|
942123-43-5
|
AT9283
|
AT9283
|
896466-04-9
|
Bafetinib
|
巴非替尼
|
887650-05-7
|
Acetamide, N-[7-[(3R)-3-[[5-chloro-4-[[2-[(1-methylethyl)sulfonyl]phenyl]amino]-2-pyrimidinyl]amino]-1-piperidinyl]heptyl]-2-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]-
|
化合物BSJ-4-116
|
2519823-34-6
|
Sotorasib
|
AMG510 單一構(gòu)型
|
2296729-00-3
|
Uridine 5'-diphosphoglucose disodium salt
|
二磷酸尿苷葡萄糖二鈉鹽
|
28053-08-9
|
EPZ031686
|
CS-2707
|
1808011-22-4
|
TNU9056
|
NU 9056
|
1450644-28-6
|
BLU-782
|
BLU-782
|
2141955-96-4
|
evobrutinib
|
埃沃布魯替尼
|
1415823-73-2
|
FASUDIL
|
法舒地爾
|
103745-39-7
|
SNDX-5613
|
SNDX-5613
|
2169919-21-3
|
FM381
|
(E)-2-CYANO-3-(5-(1-CYCLOHEXYL-1,6-DIHYDROIMIDAZO[4,5-D]PYRROLO[2,3-B]PYRIDIN-2-YL)FURAN-2-YL)-N,N-DIMETHYLACRYLAMIDE
|
2226521-65-7
|
2,3-CGAMP
|
2,3-CGAMP
|
1441190-66-4
|
VTP50469
|
VTP50469
|
2169916-18-9
|
7H-Pyrrolo[2,3-d]pyrimidin-4-amine, 7-[5-[(aminosulfonyl)amino]-5-deoxy-β-D-ribofuranosyl]-5-[2-(2-ethoxy-6-fluorophenyl)ethynyl]-
|
TAS4464
|
1848959-10-3
|
INCB8761(PF-4136309)
|
INCB8761(PF-4136309)
|
1341224-83-6
|
BMS-1166 HCl
|
BMS-1166 HCl
|
2113650-05-6
|
CDK7-IN-1
|
THZ2
|
1604810-84-5
|
KEA1-97
|
KEA1-97
|
2138882-71-8
|
IPN-60090
|
IPN-60090
|
1853164-83-6
|
VH-032
|
VH-032
|
1448188-62-2
|
Amonafide
|
氨萘非特
|
69408-81-7
|
4SC-202
|
4SC-202(鹽的形式)
|
1186222-89-8
|
IOX4
|
TERT-BUTYL 6-(5-OXO-4-(1H-1,2,3-TRIAZOL-1-YL)-2,5-DIHYDRO-1H-PYRAZOL-1-YL)NICOTINATE
|
1154097-71-8
|
(R)-N-(4-(3-aminopiperidin-1-yl)-5-bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)cyclopropanecarboxamide
|
(R)-N-(4-(3-氨基哌啶-1-基)-5-溴-1H-吡咯并[2,3-B]吡啶-3-基)環(huán)丙烷甲酰胺
|
1196541-47-5
|
ethyl 4-((4-(diethylamino)phenyl)imino)-6-methyl-1,4-dihydroquinoline-3-carboxylate
|
MCU I4
|
371924-24-2
|
BMS-1001
|
BMS-1001
|
2113650-03-4
|
DIBENZAZEPINE
|
二苯并氮卓
|
209984-56-5
|
Autophinib
|
6-CHLORO-N-(5-METHYL-1H-PYRAZOL-3-YL)-2-(4-NITROPHENOXY)PYRIMIDIN-4-AMINE
|
1644443-47-9
|
Tepotinib
|
特泊替尼
|
1100598-32-0
|
NVP-BAW2881
|
BAW2881
|
861875-60-7
|
APY29
|
APY29
|
1216665-49-4
|
Pyrido[2,3-d]pyriMidin-7(8H)-one, 6-(2,4-dichlorophenyl)-8-ethyl-2-[[3-fluoro-4-(1-piperazinyl)phenyl]aMino]-
|
FRAX486
|
1232030-35-1
|
PD-166866
|
PD-166866
|
192705-79-6
|
Tasisulam
|
他斯索蘭
|
519055-62-0
|
Olmutinib
|
奧莫替尼
|
1353550-13-6
|
UNC0379
|
UNC0379
|
1620401-82-2
|
R1487
|
SY-R1487
|
449808-64-4
|
SAR-20347
|
CPDD1211
|
1450881-55-6
|
BIX 01294
|
BIX 01294三鹽酸鹽水合物
|
1392399-03-9
|
N-[6-(2,6-Dichlorophenyl)-2-[[4-(diethylamino)butyl]amino]pyrido[2,3-d]pyrimidin-7-yl]-N'-(1,1-dimethylethyl)urea
|
PD-161570;PF-1480232
|
192705-80-9
|
URMC-099
|
URMC-099
|
1229582-33-5
|
BIX 01294, 2-(Hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-6,7-dimethoxy-N-[1-(phenylmethyl)-4-piperidinyl]-4-quinazolinamine hydrate trihydrochloride
|
BIX 01294
|
935693-62-2
|
FH 535
|
2,5-二氯-N-(2-甲基-4-硝基苯基)苯磺酰胺
|
108409-83-2
|
Entospletinib (GS-9973)
|
GS-9973
|
1229208-44-9
|
PD 173074
|
PD173074
|
219580-11-7
|